Metrics as of 10/16/2026, 04:36 AM (Berlin time), refresh in progress.
Santhera Pharmaceuticals Holding Stock
Santhera Pharmaceuticals Holding AG
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Switzerland
- CEO
- Orlando Oliveira
- Employees
- 78
- Market cap
- CHF223 M
- IPO
- 03/11/2006
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company that, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases characterized by high unmet medical need. The company operates in the regions of Europe, North America, and Asia. Its lead pipeline…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Santhera Pharmaceuticals Holding stock: price history
1D
+3.8%
1W
+3.3%
1M
-6.3%
6M
-15.5%
YTD
+15.9%
1Y
+47.5%
2Y
+61.3%
5Y
+4.3%
10Y
-97.2%
Next earnings date
Next earnings date
29/04/2027 (in 194 days)
Volatility around earnings
~18% weaker price swings than usual
Ask the agents about Santhera Pharmaceuticals Holding
Santhera Pharmaceuticals Holding stock metrics
P/E
-6.4
P/B
-33.94
EV/EBITDA
-66.36
RETURN ON EQUITY
348.7%
NET MARGIN
-44.5%
DEBT/EQUITY
-6.69
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
78.9%
FLOAT SHARES
12,070,794
AVG. DAILY VOLUME (30D)
67,627
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Santhera Pharmaceuticals Holding stock
What does Santhera Pharmaceuticals Holding do?
Santhera Pharmaceuticals Holding AG is a company in the Healthcare sector, Biotechnology industry, headquartered in Switzerland.
The CEO is Orlando Oliveira, the company employs around 78 people.
The IPO was on 03/11/2006; the stock trades on SIX under the ticker SANN.SW.
When does Santhera Pharmaceuticals Holding report next?
The next earnings date is 29/04/2027.
Around past earnings, price swings were roughly -18% stronger than usual.
Does Santhera Pharmaceuticals Holding pay a dividend?
No, Santhera Pharmaceuticals Holding currently does not pay a dividend.
Which stocks are comparable to Santhera Pharmaceuticals Holding?
Comparable stocks include BeOne Medicines, Pharvaris, Idorsia, Basilea Pharmaceutica, Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals and argenx.
How can I get Santhera Pharmaceuticals Holding stock analyzed?
Clicking "Analyze stock" lets five strategies assess Santhera Pharmaceuticals Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.